Similar content being viewed by others Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are standard-of-care agents that provide potent glucose-lowering without hypoglycemia, together with weight reduction and cardiovascular and renal benefits
The litigation centers on core product liability issues, particularly whether the drugs mechanism of slowing gastric emptying created foreseeable risks of serious harm and whether warnings and labeling adequately reflected those dangers
The company was using a false or misleading label claiming that one of its products has been approved by the FDA
Notably, the results revealed enhanced liver function following HepLPCs infusion, indicating significant improvements in cirrhosis indicators over a 6-month observation period
The formula is well-rounded and uses ingredients found in scientific studies
Author contributions RC: Writing review & editing, Writing original draft